Balance Labs, Inc.
BLNC
$1.55
-$0.02-1.27%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 852.73% | 26,569.56% | 290.60% | 1.30% | 8.32% |
| Gross Profit | -786.67% | -26,556.87% | -290.60% | -1.30% | -8.32% |
| SG&A Expenses | 67.92% | 664.67% | -23.31% | 177.78% | 46.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 560.91% | 19,810.00% | 152.21% | 36.96% | 19.94% |
| Operating Income | -519.42% | -19,800.63% | -152.21% | -36.96% | -19.94% |
| Income Before Tax | 2,878.13% | -23,707.22% | -1,764.47% | -45.08% | 94.53% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2,878.13% | -23,707.22% | -1,764.47% | -45.08% | 94.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2,878.13% | -23,707.22% | -1,764.47% | -45.08% | 94.53% |
| EBIT | -519.42% | -19,800.63% | -152.21% | -36.96% | -19.94% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 1,366.67% | -13,724.07% | -1,735.96% | -45.65% | 94.44% |
| Normalized Basic EPS | -71.79% | -5,331.43% | -2,314.29% | -18.18% | -11.43% |
| EPS Diluted | 1,366.67% | -13,724.07% | -1,735.96% | -117.39% | 94.44% |
| Normalized Diluted EPS | -103.03% | -5,331.43% | -2,314.29% | -18.18% | 5.71% |
| Average Basic Shares Outstanding | 116.17% | 73.19% | 1.53% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 80.80% | 73.19% | 1.53% | 0.00% | 19.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |